PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $200,869 | -16.0% | 4,939 | 0.0% | 0.03% | -23.7% |
| Q1 2023 | $239,245 | -3.5% | 4,939 | 0.0% | 0.04% | -19.1% |
| Q3 2022 | $248,000 | +3.8% | 4,939 | -23.0% | 0.05% | +27.0% |
| Q1 2022 | $239,000 | -6.3% | 6,413 | 0.0% | 0.04% | -2.6% |
| Q4 2021 | $255,000 | +6.7% | 6,413 | 0.0% | 0.04% | -2.6% |
| Q3 2021 | $239,000 | -11.8% | 6,413 | 0.0% | 0.04% | -11.4% |
| Q2 2021 | $271,000 | -10.9% | 6,413 | 0.0% | 0.04% | -18.5% |
| Q1 2021 | $304,000 | -22.3% | 6,413 | 0.0% | 0.05% | -28.0% |
| Q4 2020 | $391,000 | +30.3% | 6,413 | 0.0% | 0.08% | +13.6% |
| Q3 2020 | $300,000 | -7.7% | 6,413 | 0.0% | 0.07% | -18.5% |
| Q2 2020 | $325,000 | +13.6% | 6,413 | 0.0% | 0.08% | -8.0% |
| Q1 2020 | $286,000 | -7.1% | 6,413 | 0.0% | 0.09% | +15.8% |
| Q4 2019 | $308,000 | +41.9% | 6,413 | 0.0% | 0.08% | +26.7% |
| Q3 2019 | $217,000 | – | 6,413 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |